1 / 6

Antibody Therapy Market by Type, Application, Element - Global Trends 2028

The Antibody Therapy Market study focuses major leading industry players with information such as company profiles, product picture and specification, capacity, production, price, cost, revenue and contact information. It provides information on trends and developments, and focuses on markets and materials, capacities and technologies, and on the changing structure.

energy010
Download Presentation

Antibody Therapy Market by Type, Application, Element - Global Trends 2028

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Antibody Therapy Market, Share, Growth, Trends and Forecast to 2028: Global Market Insights © 2022 Global Market Insights, Inc. USA. All Rights Reserved www.gminsights.com

  2. Global Market Scenario of Antibody Therapy Market • Global Market Insights recently introduced report on global Antibody Therapy Market report is an in-depth study providing complete analysis of the industry for the period 2022 to 2028. It provides complete overview of the industry considering all the major industry trends, market dynamics and competitive scenario. • Following the onset of COVID-19, there was a prevalent need to identify effective treatments for the infection. To that effect, in October 2021, the FDA granted Emergency Use Authorization to several monoclonal antibody treatments as a therapy for COVID-19. • Browse key industry insights spread across 160 pages with 183 market data tables & 14 figures & charts from the report, “Antibody Therapy Market Forecasts By Type (Monoclonal Antibodies [mAbs] {Oncology, Autoimmune Diseases, Infectious Diseases}, Antibody-Drug Conjugates [ADCs]), End-use (Hospitals, Specialty Centers), Industry Analysis Report, Regional, Growth Potential, Competitive Market Share & Forecast, 2022 – 2028” in detail along with the table of contents: • https://www.gminsights.com/industry-analysis/antibody-therapy-market © 2022 Global Market Insights, Inc. USA. All Rights Reserved www.gminsights.com

  3. Continue:- • Moreover, in December 2021, the FDA broadened the potential use of monoclonal antibody treatment for precautionary therapy in persons at risk due to confirmed infection exposure. The approval was derived from the results of a significant clinical investigation, which discovered that the antibodies avoided symptoms in household contacts of patients who had recently tested positive. • Furthermore, due to the rising demand for antibody therapy in the market, governments and leading market participants have been increasingly investing in R&D activities, which has been favorable for business growth. For instance, in January 2022, AbbVie Inc., a major biopharmaceutical company, announced that the FDA had awarded Breakthrough Therapy Designation to Teliso-V for use in patients with advanced/metastatic EGFR (epidermal growth factor receptor) wild type, nonsquamous non-small cell lung cancer with high levels of c-Met overexpression whose disease advanced on or after platinum-based therapy. © 2022 Global Market Insights, Inc. USA. All Rights Reserved www.gminsights.com

  4. 360° Industry Analysis • In another instance, in February 2022, the World Health Organization (WHO) prequalified a monoclonal antibody "tocilizumab" to increase access to treatments for coronavirus. WHO has prequalified six antibody therapies previously, including the three presentations (three vials, each with a different quantity) of tocilizumab. As a result, growing prominence of antibody therapy as a treatment method for COVID-19 has fostered industry outlook during the pandemic. • The antibody therapy market has been segmented on the basis of type, end use, and region. Based on type, the antibody therapy market has further been segregated into monoclonal antibody (mAbs) and antibody-drug conjugates. The antibody-drug conjugates sub-segment held a market share of nearly 3% in 2021 and is estimated to grow significantly through the forecast period owing to the growing prevalence rate of cancer worldwide and increasing need for advance therapy for cancer patients. Additionally, rising R&D activities and favorable regulatory scenario are likely to proliferate segmental demand. © 2022 Global Market Insights, Inc. USA. All Rights Reserved www.gminsights.com

  5. Competitive Analysis: • AbbVie Inc • Amgen • Bristol Myers Squibb • GlaxoSmithKline plc • Takeda Pharmaceuticals • Eli Lilly and Company • Browse Complete Summary of this report @https://www.gminsights.com/industry-analysis/antibody-therapy-market © 2022 Global Market Insights, Inc. USA. All Rights Reserved www.gminsights.com

  6. Stay In Touch You can visit us at: www.gminsights.com Thank You…! © 2022 Global Market Insights, Inc. USA. All Rights Reserved www.gminsights.com

More Related